Current BMS Fellows

'Harnessing the Graft-versus-Leukaemia (GvL) Effect in Acute Myeloid Leukaemia'

PI: Paresh Vyas

'In vivo human immune challenge to determine the pharmacology and mechanism of action of immunomodulatory therapeutics'

PI: James Fullerton

'Therapeutic potential of IL-18 targeting therapies in IBD - from computational biology and functional understanding towards a clinical trial'

PI: Holm Uhlig

'Clinical utility and biological impact of platelet-biased myeloid mutations'

PI: Susie Shapiro

'Single-cell analysis of autoreactive B cells'

PI: Lynn Dustin

'Novel inhibitors of immune receptor signaling'

PI: Ricardo Fernandes

'Exploring Polycomb repressive complex as therapeutic targets in high-risk multiple myeloma patient subsets'

PI: Udo Opperman

'Translational investigation of lysolipids as a therapeutic target for neuroinflammatory and neuro-degenerative disorders'

PI: Sridhar Vasudevan

'Identification of Mavacamten non-responders in genotype positive hypertrophic cardiomyopathy, HCM using human iPSCCMs'

PI: Christopher Toepfer

'New Tools for Systematic Profiling of E3 Ligases Complexes and Small Molecule Modulators'

PI: Killian Huber

'Novel biomarkers of cardiopulmonary function in heart failure with preserved ejection fraction using exercise magnetic resonance'

PI: Andrew Lewis

'Identification of novel therapeutic targets and disease biomarkers in human liver fibrosis by dissecting cellular heterogeneity'

PI: Jagdeep Nanchahal

'Target safety and efficacy evaluation in chronic heart failure using human-based modelling and simulation.'

PI: Blanca Rodriguez